Atlas Trials

Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma

Clinical trial NCT01148108 · COMPLETED

Trial details

NCT number
NCT01148108
Sponsor
Telik
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mantle Cell LymphomaB Cell LymphomaMultiple Myeloma
Start date
2010-06-01
Primary completion
2012-09-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.